Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Participants: 17
  • Start Date: January 2021
Hyperprolactinemia and Adrenal Steroidogenesis: is There a Link?
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug, Procedure
  • Participants: 880
  • Start Date: June 21, 2019
PRolaCT - Three Multicenter Prolactinoma Randomized Clinical Trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Drug, Other
  • Participants: 50
  • Start Date: December 1, 2018
The Predictive Value of Positron Emission Tomography-Magnetic Resonance (PET-MR) Mediated Dopamine D2 Receptors Imaging in the Drug Therapy of of Prolactinomas.
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 23
  • Start Date: September 16, 2016
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole: A Dose Escalation Study of Efficacy and Tolerability
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Procedure, Drug
  • Participants: 394
  • Start Date: January 1, 2016
Prospective Randomized Clinical Study on Transsphenoidal or Dopamine Drugs Therapy Treat Non-invasive Prolactinoma
Clinical Trial
  • Status: Active, not recruiting
  • Intervention Type: Other, Behavioral
  • Participants: 45
  • Start Date: April 10, 2015
Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)
Clinical Trial
  • Status: Recruiting
  • Participants: 150
  • Start Date: March 2007
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Clinical Trial
  • Status: Active, not recruiting
  • Participants: 1500
  • Start Date: January 1, 2000
Long Term Outcome Study in Patients With Pituitary Disorders
Showing 1-11 of 11